New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control
Recruiting now
This study tests whether adding the drug adebrelimab to standard chemotherapy before surgery can help eliminate or shrink esophageal cancer more effectively. About 25 people with stage II/III esophageal squamous cell carcinoma will receive the combination, then have surgery. Rese…
Phase: NA • Sponsor: The Second Hospital of Shandong University • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC